{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2017-07-04&registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&registeredInterest=false&_metadata=all&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&_page=0&registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2017-07-04&registeredInterest=false&hansardHeading=Visual+Impairment%3A+Medical+Treatments&max-answer.dateOfAnswer=2017-07-12", "items" : [{"_about" : "http://data.parliament.uk/resources/748193", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/748193/answer", "answerText" : {"_value" : "<p>It is for local National Health Service commissioners to make decisions on whether to fund new treatments, taking into account National Institute for Health and Care Excellence guidance, available evidence and individual patient\u2019s clinical circumstances.<\/p><p> <\/p><p>The future availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2017-07-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2017-07-07T09:56:28.037Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Visual Impairment: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, when magnetic implants to improve eyesight will be available on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "2707"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}